Towards precision oncology in RET-aberrant cancers

Vivek Subbiah; Jason Roszik

doi:10.1080/15384101.2017.1302235

Towards precision oncology in RET-aberrant cancers

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	813-814
Number of pages	2
Journal	Cell Cycle
Volume	16
Issue number	9
DOIs	https://doi.org/10.1080/15384101.2017.1302235
State	Published - May 3 2017

ASJC Scopus subject areas

Molecular Biology
Developmental Biology
Cell Biology

Access to Document

10.1080/15384101.2017.1302235

Cite this

@article{f65f10c14f7c48908e2b0265fdef5c85,

title = "Towards precision oncology in RET-aberrant cancers",

author = "Vivek Subbiah and Jason Roszik",

year = "2017",

month = may,

day = "3",

doi = "10.1080/15384101.2017.1302235",

language = "English (US)",

volume = "16",

pages = "813--814",

journal = "Cell Cycle",

issn = "1538-4101",

publisher = "Landes Bioscience",

number = "9",

}

TY - JOUR

T1 - Towards precision oncology in RET-aberrant cancers

AU - Subbiah, Vivek

AU - Roszik, Jason

PY - 2017/5/3

Y1 - 2017/5/3

UR - http://www.scopus.com/inward/record.url?scp=85016106688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016106688&partnerID=8YFLogxK

U2 - 10.1080/15384101.2017.1302235

DO - 10.1080/15384101.2017.1302235

M3 - Comment/debate

C2 - 28318386

AN - SCOPUS:85016106688

SN - 1538-4101

VL - 16

SP - 813

EP - 814

JO - Cell Cycle

JF - Cell Cycle

IS - 9

ER -

Towards precision oncology in RET-aberrant cancers

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this